银屑病关节炎注册研究与队列研究中的结局指标:27个注册研究或16,183例患者的系统文献综述
该系统综述检索2010年至2020年3月Pubmed Medline,分析27个银屑病关节炎注册研究或纵向队列共16,183例患者,发现共采集58种不同结局指标;疾病活动复合评分用于74%注册研究,关节和皮肤受累报告率最高,而附着点炎、指趾炎和轴向受累报告较少,结局指标采集异质性大。
要点
- 27个注册研究共16,183例患者,加权平均年龄49.7±9.3岁,加权平均病程6.8±0.2年。
- 74%注册研究使用疾病活动复合评分,最常用MDA(41%)、DAS28(33%)和DAPSA(30%)。
- 关节受累报告率96%,皮肤银屑病93%,附着点炎77%、指趾炎74%、轴向受累52%。
核心结论
- 银屑病关节炎注册研究和队列研究的结局指标采集高度异质,需要国际共识统一结局指标。
研究设计与样本
- 系统文献综述,检索Pubmed Medline(PROSPERO CRD42020175745),纳入2010年至2020年3月发表的银屑病关节炎注册研究或纵向队列研究文章,排除以药物为中心或非银屑病关节炎特异性的注册研究、试验及长期扩展研究,共分析73篇文章、27个注册研究/队列。
主要发现
- 共纳入16,183例患者,每项研究平均599例,51%为男性,加权平均年龄49.7±9.3岁,加权平均病程6.8±0.2年。
- 共采集58种不同结局指标,疾病活动复合评分用于20/27(74%)注册研究,涉及8种不同评分。
- 关节受累报告于26/27(96%)注册研究,其中85%使用66/68关节计数;皮肤银屑病报告于93%,其中72%使用PASI。
- 附着点炎、指趾炎和轴向受累报告率分别为77%、74%和52%。
- 22/27(82%)研究报告HAQ,其他常用患者报告结局为患者总体评估(70%)和疼痛(63%)。
关键数值与推荐
- 疾病活动复合评分中最常用最小疾病活动度(MDA)41%、DAS28 33%和DAPSA 30%。
- 关节受累通过66/68关节计数报告占85%,皮肤银屑病通过PASI报告占72%。
临床怎么用
- 临床选用结局指标时需注意银屑病关节炎注册研究间异质性大,应结合关节、皮肤、附着点炎、指趾炎、轴向受累及患者报告结局等多维度评估。
局限性
- 原文未报告
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Psoriatic arthritis (PsA) is a multidimensional inflammatory disease for which multiple outcome measures can be used to assess disease activity. In 2006, the OMERACT has proposed the first core domain set in PsA. Since 2006, much work has been performed on outcome measures in PsA. OBJECTIVES: The purpose of this study was to assess outcome measures collected in recent PsA registries or longitudinal cohorts. METHODS: A systematic literature review was performed in Pubmed Medline (PROSPERO CRD42020175745) to identify all articles reporting on either registries or longitudinal cohorts in PsA, published between 2010 and March 2020. Registries centered on drugs or not PsA-specific, trials and long-term extension studies were excluded. The data collection comprised patient characteristics and the clinical outcome measures reported, including composite scores and patient reported outcomes (PROs). Statistics were descriptive. RESULTS: Of 673 articles, 73 were analysed, reporting on 27 registries/cohorts. Overall, 16,183 patients were included, with a mean of 599 per study; 51% were men, weighted mean age was 49.7 ± 9.3 years and weighted mean disease duration was 6.8 ± 0.2 years. Overall, 58 different outcome measures were collected. Disease activity composite scores were used in 20/27 (74%) registries through 8 different scores (most frequently Minimal Disease Activity: 41%, DAS28: 33% and DAPSA: 30%). Among the domains of PsA, joint involvement was reported in 26/27 (96%) registries (through the 66/68 joint count: 85%) and skin psoriasis in 93% (through PASI: 72%), whereas enthesitis, dactylitis and axial involvement were less often reported (respectively, 77%, 74% and 52%). Furthermore, 22/27 (82%) studies reported HAQ; the other frequently reported PROs were patient global assessment (70%) and pain (63%). CONCLUSIONS: Data collection in PsA is very heterogeneous, reflecting the need for international consensus on outcome measures.
引用
- Aouad K, Moysidou G, Rakotozafiarison A, et al. Outcome measures used in psoriatic arthritis registries and cohorts: A systematic literature review of 27 registries or 16,183 patients. Semin Arthritis Rheum. 2021. PMID: 34198147. doi:10.1016/j.semarthrit.2021.06.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。